Savior Lifetec (4167) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, Savior Lifetec (4167) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-98.65 Million ≈ $-3.11 Million USD) by net assets (NT$3.78 Billion ≈ $119.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4167 company net worth for the company's overall valuation and market capitalisation.

Savior Lifetec - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Savior Lifetec's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Savior Lifetec Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Savior Lifetec ranked by their cash flow conversion efficiency. Explore Savior Lifetec (4167) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Formosa Oilseed Processing Co Ltd
TW:1225
-0.011x
IM Vinaria Purcari SRL
RO:WINE
0.027x
Bank Yudha Bhakti Tbk
JK:BBYB
0.020x
Josef Manner & Comp. AG
VI:MAN
-0.119x
HARIM Co. Ltd
KQ:136480
0.021x
Autosports Group Ltd
AU:ASG
0.043x
Studio City International Holdings Ltd
NYSE:MSC
0.015x
Oriental Interest Bhd
KLSE:5827
0.016x

Annual Cash Flow Conversion Efficiency for Savior Lifetec (2011–2025)

The table below shows the annual cash flow conversion efficiency of Savior Lifetec from 2011 to 2025. View latest Savior Lifetec stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$3.78 Billion
≈ $119.12 Million
NT$-21.04 Million
≈ $-662.91K
-0.006x -103.77%
2024-12-31 NT$3.52 Billion
≈ $110.78 Million
NT$518.38 Million
≈ $16.33 Million
0.147x +27.87%
2023-12-31 NT$3.36 Billion
≈ $106.01 Million
NT$387.95 Million
≈ $12.22 Million
0.115x -33.27%
2022-12-31 NT$3.37 Billion
≈ $106.08 Million
NT$581.77 Million
≈ $18.33 Million
0.173x +440.04%
2021-12-31 NT$3.31 Billion
≈ $104.37 Million
NT$-168.34 Million
≈ $-5.30 Million
-0.051x -285.45%
2020-12-31 NT$3.33 Billion
≈ $104.92 Million
NT$91.25 Million
≈ $2.87 Million
0.027x -61.21%
2019-12-31 NT$2.21 Billion
≈ $69.75 Million
NT$156.40 Million
≈ $4.93 Million
0.071x +169.06%
2018-12-31 NT$1.86 Billion
≈ $58.47 Million
NT$-189.84 Million
≈ $-5.98 Million
-0.102x -184.82%
2017-12-31 NT$2.16 Billion
≈ $68.15 Million
NT$260.89 Million
≈ $8.22 Million
0.121x +435.93%
2016-12-31 NT$2.12 Billion
≈ $66.77 Million
NT$-76.09 Million
≈ $-2.40 Million
-0.036x +86.25%
2015-12-31 NT$1.59 Billion
≈ $50.15 Million
NT$-415.82 Million
≈ $-13.10 Million
-0.261x -265.61%
2014-12-31 NT$1.29 Billion
≈ $40.75 Million
NT$-92.41 Million
≈ $-2.91 Million
-0.071x -16.66%
2013-12-31 NT$1.39 Billion
≈ $43.93 Million
NT$-85.39 Million
≈ $-2.69 Million
-0.061x +65.70%
2012-12-31 NT$1.27 Billion
≈ $40.16 Million
NT$-227.59 Million
≈ $-7.17 Million
-0.179x +48.89%
2011-12-31 NT$1.31 Billion
≈ $41.38 Million
NT$-458.82 Million
≈ $-14.46 Million
-0.349x --

About Savior Lifetec

TWO:4167 Taiwan Biotechnology
Market Cap
$190.72 Million
NT$6.05 Billion TWD
Market Cap Rank
#16821 Global
#819 in Taiwan
Share Price
NT$19.50
Change (1 day)
+2.09%
52-Week Range
NT$16.70 - NT$21.85
All Time High
NT$40.63
About

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more